Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues
Authors
Keywords
-
Journal
Arrhythmia & Electrophysiology Review
Volume 12, Issue -, Pages -
Publisher
Radcliffe Media Media Ltd
Online
2023-05-30
DOI
10.15420/aer.2023.04
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ventricular Arrhythmias and Sudden Death Events following Acalabrutinib initiation
- (2022) Seema A Bhat et al. BLOOD
- The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: Insights from National Inpatient Sample
- (2022) Sahith Reddy Thotamgari et al. EUROPEAN JOURNAL OF CANCER
- The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
- (2022) Eline L Giraud et al. LANCET ONCOLOGY
- Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
- (2021) Daniel A Zlotoff et al. Journal for ImmunoTherapy of Cancer
- Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
- (2021) Michael G. Fradley et al. CIRCULATION
- Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study
- (2021) Joe-Elie Salem et al. EUROPEAN HEART JOURNAL
- Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis
- (2021) Nestor Rubio‐Infante et al. EUROPEAN JOURNAL OF HEART FAILURE
- Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery
- (2021) Ashley F. Stein‐Merlob et al. ESC Heart Failure
- Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
- (2021) Joerg Herrmann et al. EUROPEAN HEART JOURNAL
- Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy
- (2021) Adam Goldman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies
- (2021) Janice M. Bonsu et al. JAMA Oncology
- Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
- (2021) Mengfei Cheng et al. Frontiers in Cardiovascular Medicine
- Prevalence and in-hospital outcomes of patients with malignancies undergoing de novo cardiac electronic device implantation in the USA
- (2020) Mohamed O Mohamed et al. EUROPACE
- Risk of QTc Prolongation Among Cancer Patients Treated with Tyrosine Kinase Inhibitors
- (2020) Anan A. Abu Rmilah et al. INTERNATIONAL JOURNAL OF CANCER
- Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy
- (2020) Ziliang Chen et al. JOURNAL OF ELECTROCARDIOLOGY
- Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study
- (2020) Markus S Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy
- (2020) Xufei Liang et al. Cardiology Research and Practice
- A current understanding of drug-induced QT prolongation and its implications for anticancer therapy
- (2019) Dan M Roden CARDIOVASCULAR RESEARCH
- Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy
- (2019) Muhammet Dural et al. JOURNAL OF ELECTROCARDIOLOGY
- A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma
- (2019) Muhammet Gurdogan et al. Oncology Research and Treatment
- Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy
- (2019) Jagmeet P. Singh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
- (2018) Syed Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities
- (2018) Avirup Guha et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies
- (2018) Avirup Guha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents
- (2018) Andrew C. Nickel et al. Journal of the American Heart Association
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- Use and misuse of common terminology criteria for adverse events in cancer clinical trials
- (2016) Sheng Zhang et al. BMC CANCER
- Which QT Correction Formulae to Use for QT Monitoring?
- (2016) Bert Vandenberk et al. Journal of the American Heart Association
- Radiotherapy Induces Development of Fragmented QRS in Patients with Breast Cancer
- (2015) Adem Adar et al. Breast Care
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- α-Lipoic acid protects against arsenic trioxide-induced acute QT prolongation in anesthetized guinea pigs
- (2013) Masafumi Kumazaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs
- (2012) A. Naing et al. ANNALS OF ONCOLOGY
- Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials
- (2012) Mitesh J. Borad et al. INVESTIGATIONAL NEW DRUGS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Benign cardiac tumours, malignant arrhythmias
- (2011) Kimberley A. Myers et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia
- (2011) Christina Y. Miyake et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis
- (2011) Sandeep Sagar et al. LANCET
- Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
- (2010) Raoul C. Reulen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessing proarrhythmic potential of drugs when optimal studies are infeasible
- (2009) Edwin P. Rock et al. AMERICAN HEART JOURNAL
- Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for IKs
- (2009) J Ducroq et al. BRITISH JOURNAL OF PHARMACOLOGY
- Introducing a new entity: chemotherapy-induced arrhythmia
- (2009) M. Guglin et al. EUROPACE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now